Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model

Derek J.B. Kleinveld*, Liza Botros, M. Adrie W. Maas, Jesper Kers, Jurjan Aman, Markus W. Hollmann, Nicole P. Juffermans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Background: Trauma-induced shock is associated with endothelial dysfunction. We examined whether the tyrosine kinase inhibitor bosutinib as an adjunct therapy to a balanced blood component resuscitation strategy reduces trauma-induced endothelial permeability, thereby improving shock reversal and limiting transfusion requirements and organ failure in a rat polytrauma transfusion model. Methods: Male Sprague–Dawley rats (n=13 per group) were traumatised and exsanguinated until a MAP of 40 mm Hg was reached, then randomised to two groups: red blood cells, plasma and platelets in a 1:1:1 ratio with either bosutinib or vehicle. Controls were randomised to sham (median laparotomy, no trauma) with bosutinib or vehicle. Organs were harvested for histology and wet/dry (W/D) weight ratio. Results: Traumatic injury resulted in shock, with higher lactate levels compared with controls. In trauma-induced shock, the resuscitation volume needed to obtain a MAP of 60 mm Hg was lower in bosutinib-treated animals (2.8 [2.7–3.2] ml kg−1) compared with vehicle (6.1 [5.1–7.2] ml kg−1, P<0.001). Lactate levels in the bosutinib group were 2.9 [1.7–4.8] mM compared with 6.2 [3.1–14.1] mM in the vehicle group (P=0.06). Bosutinib compared with vehicle reduced lung vascular leakage (W/D ratio of 5.1 [4.6–5.3] vs 5.7 [5.4–6.0] (P=0.046) and lung injury scores (P=0.027). Conclusions: Bosutinib as an adjunct therapy to a balanced transfusion strategy reduced resuscitation volume, improved shock reversal, and reduced vascular leak and organ injury in a rat polytrauma model.

Original languageEnglish
Pages (from-to)958-966
Number of pages9
JournalBritish Journal of Anaesthesia
Issue number5
Publication statusPublished - May 2021

Cite this